BackProtagenic Therapeutics Overview

Protagenic Therapeutics Operating Income

Operating Income for PTIX.

Quarterly Operating Income

$-925103.00
↓ 43.69% YoY

As of Dec 31, 2025

Annual Operating Income (TTM)

$-5831487.00
↑ 2.29% YoY

Trailing 12 months ending Dec 31, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin